Locations:
Search IconSearch
December 6, 2017/Opinion

An Rx for Drug Prices: D.C. should drop the rhetoric and pass this one reform

In Newsweek op-ed, Chief Pharmacy Officer Scott Knoer calls for increased competition and expedited approval of generic/biosimilar drugs

Media Contact

Cleveland Clinic News Service | 216.444.0141

We’re available to shoot custom interviews & b-roll for media outlets upon request.

Media Downloads

CCNS health and medical content is consumer-friendly, professional broadcast quality (available in HD), and available to media outlets each day.

Opioid Oped
Scott Knoer, M.S., Pharm.D., Chief Pharmacy Officer

Politicians on all sides have talked about the need for drug price reform. Yet, despite the rhetoric, not a single federal law related to drug prices has passed.

It’s time to move past the empty promises and generate tangible results, Cleveland Clinic Pharmacy Officer Scott Knoer argues in a Newsweek op-ed.

While there are many potential solutions to the drug price problem, let’s focus on just one simple approach that is proven to be effective – increase competition in the marketplace by:

  • Passing the CREATES Act, which would allow generic versions of drugs to get to market faster after the patent protection ends.
  • Speeding up the approval and use of gneric and biosimilar drugs.

Read the entire piece at Newsweek.com: HOW TO REDUCE MEDICAL DRUG PRICES AT A STROKE

Latest from the Newsroom